Search
Kenneth Marians focuses on mechanisms of replication restart and chromosome segregation.
Associate Attending Computer Scientist Harini Veeraraghavan's lab develops and translates new AI and machine learning tools diagnosing and personalizing cancer treatments through automated segmentation of normal tissues and tumors applied to radiation treatment automation, early predicting treatment response and toxicity prediction, and longitudinal tumor treatment response monitoring from medical images.
Cell biologist Meng-Fu Bryan Tsou studies cell cycle control of centrosome duplication and degeneration, as well as cilia assembly and disassembly.
The Lee laboratory studies the mechanisms governing homeostatic turnover and reparative programs in stem cells, with a focus on elucidating how tissue perturbations lead to lung disease.
Craig Thompson studies molecular signaling pathways that regulate nutrient uptake and the role these pathways play in the regulation of cell growth and survival.
Physician-scientist Rachel Niec studies how cells and tissues communicate to promote health or drive inflammation and cancer.
The Ricardo Otazo lab develops novel magnetic resonance imaging (MRI) techniques for cancer applications including fast imaging, motion tolerant imaging, quantitative imaging of physical tissue parameters, and real-time MRI-guided radiotherapy using advances in MRI acquisition and computational models.
Radiologist and Nuclear Medicine physician Jan Grimm develops novel approaches for improved diagnosis, monitoring and therapy of prostate and other cancers.
My laboratory and clinical research focus on understanding genomics and signaling in colorectal cancer to develop new treatments for patients.
Computational chemist John Chodera uses statistical mechanics, molecular modeling, and automated biophysical experiments to help identify new potential therapeutics and investigate mechanisms of drug resistance in cancer.